Cresco Labs (CRLBF) Intangibles (2019 - 2026)
Cresco Labs (CRLBF) posted Intangibles of $288.4 million for Q1 2026, up 4.76% on a QoQ basis from $275.3 million in Q4 2025, and down 1.66% year-over-year from $293.3 million in Q1 2025.
Cresco Labs (CRLBF) Intangibles (2019 - 2026) Analysis & Trends
Cresco Labs' Intangibles history runs 8 years deep, the most recent figure standing at $288.4 million for Q1 2026.
- Quarterly Intangibles fell 1.66% year-over-year to $288.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.4 million (down 1.66% YoY) and the FY2025 annual result came in at $275.3 million, down 6.34% from the prior year.
- Intangibles was $288.4 million for Q1 2026 at Cresco Labs, up from $275.3 million in the prior quarter.
- Across five years, Intangibles topped out at $435.9 million in Q1 2022 and bottomed at $275.3 million in Q4 2025.
- A 5-year average of $337.5 million and a median of $298.0 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles jumped 655.6% — and 2023, when it sank 30.93%.
- Cresco Labs' Intangibles stood at $407.6 million in 2022, then retreated by 27.14% to $297.0 million in 2023, then retreated by 1.0% to $294.0 million in 2024, then fell by 6.34% to $275.3 million in 2025, then increased by 4.76% to $288.4 million in 2026.
- Business Quant data shows CRLBF's Intangibles at $288.4 million in Q1 2026, $275.3 million in Q4 2025, and $292.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 288.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288.45 Mn |
| Dec 31, 2025 | 275.34 Mn |
| Sep 30, 2025 | 292.00 Mn |
| Jun 30, 2025 | 289.27 Mn |
| Mar 31, 2025 | 293.32 Mn |
| Dec 31, 2024 | 293.99 Mn |
| Sep 30, 2024 | 295.65 Mn |
| Jun 30, 2024 | 299.99 Mn |
| Mar 31, 2024 | 298.07 Mn |
| Dec 31, 2023 | 296.97 Mn |
| Sep 30, 2023 | 298.01 Mn |
| Jun 30, 2023 | 402.80 Mn |
| Mar 31, 2023 | 406.10 Mn |
| Dec 31, 2022 | 407.59 Mn |
| Sep 30, 2022 | 431.45 Mn |
| Jun 30, 2022 | 433.35 Mn |
| Mar 31, 2022 | 435.93 Mn |
| Dec 31, 2021 | 437.64 Mn |
| Sep 30, 2021 | 57.10 Mn |
| Mar 31, 2021 | 215.25 Mn |